Cargando…
A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain
Breakthrough pain (BTP) is a transitory pain (reaching maximum severity in ∼15 minutes and lasting ∼60 minutes in patients with cancer) that occurs despite the management of chronic pain with long-term around-the-clock analgesia. BTP occurs in 33–65% of patients with chronic cancer pain and in ∼70%...
Autor principal: | Smith, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625411/ https://www.ncbi.nlm.nih.gov/pubmed/22668247 http://dx.doi.org/10.2165/11630580-000000000-00000 |
Ejemplares similares
-
Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Smith, Howard S
Publicado: (2013) -
Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Perelman, Michael, et al.
Publicado: (2013) -
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice
por: Bossi, Paolo, et al.
Publicado: (2022) -
Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study
por: Yen, Tsung-Yu, et al.
Publicado: (2018) -
Breakthrough Pain: The Importance of Baseline Analgesic Regimen with Opioids
por: Zampi, Maddalena, et al.
Publicado: (2012)